Literature DB >> 28756993

Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies.

Marco Mina1, Franck Raynaud1, Daniele Tavernari1, Elena Battistello2, Stephanie Sungalee3, Sadegh Saghafinia2, Titouan Laessle4, Francisco Sanchez-Vega5, Nikolaus Schultz6, Elisa Oricchio3, Giovanni Ciriello7.   

Abstract

Cancer evolves through the emergence and selection of molecular alterations. Cancer genome profiling has revealed that specific events are more or less likely to be co-selected, suggesting that the selection of one event depends on the others. However, the nature of these evolutionary dependencies and their impact remain unclear. Here, we designed SELECT, an algorithmic approach to systematically identify evolutionary dependencies from alteration patterns. By analyzing 6,456 genomes from multiple tumor types, we constructed a map of oncogenic dependencies associated with cellular pathways, transcriptional readouts, and therapeutic response. Finally, modeling of cancer evolution shows that alteration dependencies emerge only under conditional selection. These results provide a framework for the design of strategies to predict cancer progression and therapeutic response.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer evolution; conditional selection; interdependent therapeutic response; oncogenic dependencies; selected events

Mesh:

Year:  2017        PMID: 28756993     DOI: 10.1016/j.ccell.2017.06.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  41 in total

1.  Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.

Authors:  Brian A Walker; Konstantinos Mavrommatis; Christopher P Wardell; T Cody Ashby; Michael Bauer; Faith E Davies; Adam Rosenthal; Hongwei Wang; Pingping Qu; Antje Hoering; Mehmet Samur; Fadi Towfic; Maria Ortiz; Erin Flynt; Zhinuan Yu; Zhihong Yang; Dan Rozelle; John Obenauer; Matthew Trotter; Daniel Auclair; Jonathan Keats; Niccolo Bolli; Mariateresa Fulciniti; Raphael Szalat; Philippe Moreau; Brian Durie; A Keith Stewart; Hartmut Goldschmidt; Marc S Raab; Hermann Einsele; Pieter Sonneveld; Jesus San Miguel; Sagar Lonial; Graham H Jackson; Kenneth C Anderson; Herve Avet-Loiseau; Nikhil Munshi; Anjan Thakurta; Gareth J Morgan
Journal:  Blood       Date:  2018-06-08       Impact factor: 22.113

2.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.

Authors:  Masaya Suenaga; Jun Yu; Koji Shindo; Koji Tamura; Jose Alejandro Almario; Christopher Zaykoski; P Dane Witmer; Shahriar Fesharakizadeh; Michael Borges; Anne-Marie Lennon; Eun-Ji Shin; Marcia Irene Canto; Michael Goggins
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

Review 3.  Identifying Epistasis in Cancer Genomes: A Delicate Affair.

Authors:  Joris van de Haar; Sander Canisius; Michael K Yu; Emile E Voest; Lodewyk F A Wessels; Trey Ideker
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

4.  MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.

Authors:  Sisheng Liu; Jinpeng Liu; Yanqi Xie; Tingting Zhai; Eugene W Hinderer; Arnold J Stromberg; Nathan L Vanderford; Jill M Kolesar; Hunter N B Moseley; Li Chen; Chunming Liu; Chi Wang
Journal:  Bioinformatics       Date:  2021-06-09       Impact factor: 6.937

5.  Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.

Authors:  Ermin Hodzic; Raunak Shrestha; Kaiyuan Zhu; Kuoyuan Cheng; Colin C Collins; S Cenk Sahinalp
Journal:  Gigascience       Date:  2019-04-01       Impact factor: 6.524

6.  RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.

Authors:  Takuo Hayashi; Patrice Desmeules; Roger S Smith; Alexander Drilon; Romel Somwar; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2017-11-10       Impact factor: 12.531

7.  Genetics: Conditional selection determines the pathways of cancer evolution.

Authors:  David Killock
Journal:  Nat Rev Clin Oncol       Date:  2017-08-22       Impact factor: 66.675

8.  Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.

Authors:  Jian Zhou; Francisco Sanchez-Vega; Raul Caso; Kay See Tan; Whitney S Brandt; Gregory D Jones; Shi Yan; Prasad S Adusumilli; Matthew Bott; James Huang; James M Isbell; Smita Sihag; Daniela Molena; Valerie W Rusch; Walid K Chatila; Natasha Rekhtman; Fan Yang; Marc Ladanyi; David B Solit; Michael F Berger; Nikolaus Schultz; David R Jones
Journal:  Clin Cancer Res       Date:  2019-08-27       Impact factor: 12.531

9.  Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.

Authors:  Piotr Przanowski; Song Lou; Rachisan Djiake Tihagam; Tanmoy Mondal; Caroline Conlan; Gururaj Shivange; Ilyas Saltani; Chandrajeet Singh; Kun Xing; Benjamin B Morris; Marty W Mayo; Luis Teixeira; Jacqueline Lehmann-Che; Jogender Tushir-Singh; Sanchita Bhatnagar
Journal:  Cancer Res       Date:  2020-08-27       Impact factor: 12.701

Review 10.  Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

Authors:  Ferdinandos Skoulidis; John V Heymach
Journal:  Nat Rev Cancer       Date:  2019-08-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.